|
1
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancerMicroRNA Cancer Regulation. 774.
Schmitz U, Wolkenhauer O and Vera J: Springer; Dordrecht: pp. 1–20.
2013, View Article : Google Scholar
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang D, Zhou P, Wang W, Wang X, Li J, Sun
X and Zhang L: MicroRNA-616 promotes the migration, invasion and
epithelial-mesenchymal transition of HCC by targeting PTEN. Oncol
Rep. 35:366–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma S, Chan YP, Kwan PS, Lee TK, Yan M,
Tang KH, Ling MT, Vielkind JR, Guan XY and Chan KW: MicroRNA-616
induces androgen-independent growth of prostate cancer cells by
suppressing expression of tissue factor pathway inhibitor TFPI-2.
Cancer Res. 71:583–592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang DX, Zou YJ, Zhuang XB, Chen SX, Lin
Y, Li WL, Lin JJ and Lin ZQ: Sulforaphane suppresses EMT and
metastasis in human lung cancer through miR-616-5p-mediated
GSK3β/β-catenin signaling pathways. Acta Pharmacol Sin. 38:241–251.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moreno-Bueno G, Portillo F and Cano A:
Transcriptional regulation of cell polarity in EMT and cancer.
Oncogene. 27:6958–6969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sánchez-Tilló E, Liu Y, de Barrios O,
Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A
and Postigo A: EMT-activating transcription factors in cancer:
Beyond EMT and tumor invasiveness. Cell Mol Life Sci. 69:3429–3456.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.PubMed/NCBI
|
|
16
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kalluri R: EMT: When epithelial cells
decide to become mesenchymal-like cells. J Clin Invest.
119:1417–1419. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gotzmann J, Mikula M, Eger A,
Schulte-Hermann R, Foisner R, Beug H and Mikulits W: Molecular
aspects of epithelial cell plasticity: Implications for local tumor
invasion and metastasis. Mutat Res. 566:9–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vynios DH: TIMP2 (TIMP metallopeptidase
inhibitor 2). Atlas Genet Cytogenet Oncol Haematol. 13:229–231.
2009.
|
|
21
|
Nakopoulou L, Tsirmpa I, Alexandrou P,
Louvrou A, Ampela C, Markaki S and Davaris PS: MMP-2 protein in
invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on
overall survival. Breast Cancer Res Treat. 77:145–155. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duffy MJ, McGowan PM and Gallagher WM:
Cancer invasion and metastasis: Changing views. J Pathol.
214:283–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li P, Xu Q, Zhang D, Li X, Han L, Lei J,
Duan W, Ma Q, Wu Z and Wang Z: Upregulated miR-106a plays an
oncogenic role in pancreatic cancer. FEBS Lett. 588:705–712. 2014.
View Article : Google Scholar : PubMed/NCBI
|
